Tag: ASX: 4DX
4DMedical secures US Department of Defence contract for CT:VQ pilot program
4DMedical, a leader in advanced respiratory imaging technology, has secured a contract with the United States Department of Defence (DoD) to pilot its CT Ventilation-Perfusion (CT:VQ) technology.
University of Chicago Medicine adopts 4DMedical’s advanced imaging tech
4DMedical has secured a new partnership with the University of Chicago Medicine (UChicago Medicine), a leading academic medical centre in the United States.
4DMedical partners with Philips to expand US Defence commercialisation
ASX-listed imaging technology developer 4DMedical Limited has signed a teaming agreement with Koninklijke Philips, a leading global healthcare company, to commercialise 4D Medical’s XV Technology within the US Department of Veterans Affairs.
4DMedical receives gov’t funding to further develop lung scanner tech
Australian respiratory imaging tech company 4DMedical Limited has secured $1.1 million in funding from the Clinical Translation and Commercialisation Medtech (CTCM) program, an initiative of the Medical Research Future Fund delivered by MTPConnect.
4DMedical reveals progress in CT-based ventilation-perfusion product
Medical equipment manufacturing company 4DMedical Limited said it has made material progress in the development of its CT-based ventilation-perfusion product (CT:VQ), which quantifies and visualises regional ventilation and regional perfusion.
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
